Full Text View
Tabular View
No Study Results Posted
Related Studies
Etiology, Prevention and Treatment of Neonatal Infections in the Community
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2007 by Johns Hopkins Bloomberg School of Public Health.   Recruitment status was  Active, not recruiting

First Received on September 12, 2005.   Last Updated on April 23, 2007   History of Changes
Sponsor: Johns Hopkins Bloomberg School of Public Health
Information provided by: Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier: NCT00198627
  Purpose

The purpose of this study is to determine what are the major types of bacteria that cause newborn infections in the community in rural Bangladesh and whether providing an obstetric and neonatal care package will reduce neonatal deaths by 40%.


Condition Intervention
Bacterial Infection
Infectious Disease
Drug: Co-Trimoxazole; TMP-SMZ

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Etiology, Prevention, and Treatment of Neonatal Infections in the Community

Resource links provided by NLM:


Further study details as provided by Johns Hopkins Bloomberg School of Public Health:

Primary Outcome Measures:
  • Health workers will visit households at three month intervals for 18 months and survey the status of the babies.

Secondary Outcome Measures:
  • At anytime during the study, if the baby shows symptoms of serious infection, the health worker will offer advice on where to go for treatment, or offer to treat the baby at home.

Estimated Enrollment: 16359
Study Start Date: December 2003
Estimated Study Completion Date: September 2007
Detailed Description:

The study seeks answers to two questions:

  1. What are the major bacterial pathogens responsible for serious neonatal infections in the community in rural Bangladesh?
  2. Can provision of a package of obstetric and neonatal care, including active surveillance for serious neonatal illness and referral to hospital, and identification of barriers to care-seeking and design of strategies to address them reduce neonatal mortality rates by at least 40% compared to communities in which such services are not provided?

Despite significant decline in infant and child mortality rates in recent decades, neonatal mortality rates remain unacceptably high. Of the 8 million infant deaths that occur worldwide each year, approximately 4 million occur in the neonatal period.

Hence, the specific aims of the study include:

  1. identifying the principal agents of serious bacterial infections in Bangladeshi neonates in the community
  2. evaluating the impact of introducing a package of essential obstetric and neonatal care practices in the community, including identifying barriers to care-seeking and design of strategies to address those barriers and
  3. building capacity within Bangladesh by training Bangladeshi scientists in epidemiological and microbiological techniques, clinical research methods and best clinical practice through an on-going collaboration with Dhaka Shishu (Children) Hospital and the International Centre for Diarrhoeal Disease Research, Bangladesh.
  Eligibility

Ages Eligible for Study:   1 Month and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • pregnant women (any age)
  • newborns

Exclusion Criteria:

  • children (outside newborn period)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00198627

Locations
Bangladesh
Dhaka Shishu Hospital
Dhaka, Bangladesh
Sponsors and Collaborators
Johns Hopkins Bloomberg School of Public Health
Investigators
Principal Investigator: Gary Darmstadt, MD Johns Hopkins Bloomberg School of Public Health
  More Information

No publications provided by Johns Hopkins Bloomberg School of Public Health

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00198627     History of Changes
Other Study ID Numbers: H.22.01.09.05.A1
Study First Received: September 12, 2005
Last Updated: April 23, 2007
Health Authority: United States: Institutional Review Board;   Dhaka, Bangladesh: ICDDR,B Research Review and Ethical Review Committee;   Dhaka Bangladesh: Dhaka Shishu Hospital IRB;   United Kingdom: Oxford University IRB

Keywords provided by Johns Hopkins Bloomberg School of Public Health:
Neonatal bacterial infection

Additional relevant MeSH terms:
Bacterial Infections
Communicable Diseases
Infection
Trimethoprim-Sulfamethoxazole Combination
Anti-Infective Agents, Urinary
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Renal Agents
Antimalarials
Antiprotozoal Agents
Antiparasitic Agents

ClinicalTrials.gov processed this record on February 09, 2012